Abstract:Aim: To construct a vector expressing through target gene given by human telomerase reserve transcriptase (hTERT) promoter with pLHCX as vector and realize target expression. Methods: Experiments were performed at the Key Laboratory of Molecular Medicine from September 2005 to May 2006. 1 The phTERT-luc plasmid containing 319 bp hTERT core promoter was presented by Dr. Zheng from Military Academy of Science; Retrovirus vector pLHCX was presented by Professor Zhu from Zhejiang University; The plasmid pCMV-Neo-BamH-wtp53 containing 1.8 kb wtp53 gene was presented by Professor Zhu from Second Military Medical University of Chinese PLA; Enhanced green fluorescent protein report plasmid pEGFP-N2 and pEGFP-C1 were kept in this laboratory; human carcinoma of large intestine cell strain SW620 and HT-29, human cervical carcinoma cell strain Hela, human lung carcinoma cell strain A549, and human lung embryo fibroblast MRC-5 were kept in this laboratory. 2 The plasmid pLHCX-hTERT-EGFP expressing EGFP driven by hTERT promoter and the plasmid pLHCX-hTERT-wtp53 expressing wtp53 also driven by hTERT promoter were constructed through directional cloning. The plasmid pLHCX-hTERT-EGFP and the plasmid pLHCX-CMV-EGFP were used for the transfection of human carcinoma of large intestine cell strain SW620 and HT-29, human cervical carcinoma cell strain Hela, human lung carcinoma cell strain A549, and human lung embryo fibroblast MRC-5. 3 The flow cytometer was used to analyze the transfection efficiency of pLHCX-hTERT-EGFP so as to declare the HTERT promoter specific expression in tumor cells. The human colon cancer cell line SW620, which the p53 gene is mutation, were infected with the plasmid pLHCX-hTERT-wtp53 and p53 mRNA, p53 protein were demonstrated with RT-PCR and Western blot. The normal human embryo lung fibroblast cell strain MRC-5 and the human colon cancer cell line SW620 and HT-29 were treated with the plasmid pLHCX-hTERT-wtps3, the propagate inhibition and apoptosis of cells were detected by MTT' and FCM, respectively. Results: 1 The plasmids pLHCX-hTERT-EGFP and pLHCX-hTERT-wtp53 were successfully constructed, which were confirmed by restriction endonuclease and sequencing. Green fluorescent protein expression was observed by pLHCX-hTERT-EGFP transfection SW620. The sequencing verified that complete wtp53 fragment was found. 2 Flow cytometry declared that enhanced green fluorescent protein expression was significantly higher in the SW620, Hela and A549 than the MRC-5 after pLHCX-hTERT-EGFP treatment (P < 0.05), but no significant difference was found in positive and negative cells above mentioned (P > 0.05). 3 The expression of wtp53 mRNA and the protein were demonstrated by RT-PCR and Western blot, respectively. 4 MTT showed that recombinant plasmid had significant inhibition on carcinoma of large intestine with positive telomerase, but had no significant effects on MRC-5 cells with negative telomerase (P < 0.05). 5 Flow cytometry showed that the apoptosis of carcinoma of large intestine with positive telomerase was significantly higher than the MRC-5 cells with negative telomerase induced by recombinant plasmid (P < 0.05). Conclusion: The retroviral vector pLHCX-hTERT-EGFP can express in tumor cells specifically and the retroviral vector pLHCX-hTERT-wtp53 can affect carcinoma of large intestine with positive telomerase specifically.

[Construction of Tumor Cell-Specific Expression Vector Modulated by Human Telomerase Reserse Transcription Gene Core Promoter].

[Activity of the TNF-related Apoptosis-Inducing Ligand Gene Expressed from the Htert Promoter on Colon Cancer Cell Line HT-29].

Construction of Htert and Cox-2 Dependent Oncolytic Adenovirus

Construction of Two Different Recombinant Plasmids Containing Human Telomerase Reverse Transcriptase Gene Promoter

Construction of Expression Vector of Htert- Hil18 Fusion Gene and Induction of Cytotoxic T Lymphocyte Response Against Htert.

Construction of a Tumor-Specific Bioluminescent Eukaryotic Expression Vector and Analysis of Its Expression in Vitro and in Vivo

Construction of retroviral vector expressing wild type p53 gene driven by hTERT promoter firstly by retrovirus only infecting dividing cells

Expression of a Recombinant Vector of a Mutant Human Telomerase Reverse Transcriptase Gene in Human Bladder Cancer Cell Line T24, and Its Clinical Significance

Incorporation of Prokaryotic Enhancer for Enhancement of Gene Expression Driven by Htert Promoter

Cloning of Htert Promoter and Its Specific Transcriptional Activity in MCF7 Breast Cancer Cell

Tumor-targeted Efficiency of Shrna Vector Harboring Chimera Htert/u6 Promoter.

hTERT Core Promoter Modified by E-boxes Element and Transcriptional Activity Assay in vitro

Expression Activity of Cancer-Specific Adenovirus Vector Targeting Telomerase

Construction and expression of the vector of CD137L under the control of the hTERT promoter in human ovarian tumor cell lines

Cloning of Mouse Telomerase Reverse Transcriptase Gene Promoter and Identification of Proximal Core Promoter Sequences Essential for the Expression of Transgenes in Cancer Cells

Construction of Tumor-specific Oncolytic Adenovirus Vector and its Primary Study on Selective Expression in Tumor Cells

Noninvasive and real-time monitoring of the therapeutic response of tumors in vivo with an optimized hTERT promoter.

Construction of lentiviral expression vector with telomerase reverse transcriptase and green fluorescent protein recombinant gene

[Treatment of Ovarian Cancer Cell Line Skov3 with HSV-tk/GCV under the Control of Human Telomerase Reverse Transcriptase Gene Promoter].

Abstract# 3787: A novel hTERT promoter driven E1A therapeutic for ovarian cancer

Construction of Retroviral Vector Containing Enhanced Green Fluorescent Protein Gene Driven by Human Telomerase Reserve Transcriptase Gene Promoter and Expression in Human Cervical Cancer Hela Cell